Gonococcal antimicrobial susceptibility surveillance in Europe, 2016

surveillance report
Publication series: Gonococcal antimicrobial susceptibility surveillance in Europe
Cite:
Citation Link

European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in Europe, 2016. Stockholm: ECDC; 2018

Copy citation to clipboard

The overall aim of Euro-GASP is to strengthen the surveillance of gonococcal antimicrobial susceptibility in EU/EEA Member States in order to provide quality-assured data to inform gonorrhoea treatment guidelines. This report presents the results from the 2016 gonococcal antimicrobial susceptibility sentinel surveillance.

Read more

Drug-resistance of gonorrhoea in the EU: persistent but stable

Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP).

Related updates on Neisseria gonorrhoeae

News

Health risks during the Carnival season in Brazil

epidemiological update -

Publication

Communicable disease threats report, 6-12 January 2019, week 2

publication -

News

Call for scientific collaboration to support genomic-based surveillance of Neisseria gonorrhoeae-antimicrobial resistance at EU-level

collaboration call -

Data

Trends and data on gonorrhoea in the EU/EEA, 2016

presentation -

News

Drug-resistance of gonorrhoea in the EU: persistent but stable

news -